Summary By reanalyzing our previous study of resting ventilation and PACO2 during the menstrual cycle of eight healthy women, we found that relative to the follicular phase, a 9.4% increase in VA (p<0.05) and a 2.5 mmHg decrease in PACO2 (p<0.001) occurring during the luteal phase, both of which have been reported previously, were attributable mostly to a decrease in VD (-7.2%, 0.05<p<0.1) but not to an increase in VE (+1.9%, N.S.), the latter two changes producing an 8.7% decrease in VD/ VT (p<0.01).
It is known that progesterone and some progestational agents cause hyperventilation and a fall in PACO2 (SKATRUD et al., 1978) . Due to this effect, physiologically, normal adult women exhibit a 2-8 mmHg drop in PACO2 during the luteal phase of the menstrual cycle (ENGLAND and FARHI, 1976) and further drops during pregnancy (Lucius et al., 1970; PERNOLL et al., 1975) . Since progesterone has little effect on CO2 production (TYLER, 1960; SKATRUD et al., 1980; TAKANO et al., 1981) , the decrease in PACO2 during progesterone stimulation was ascribed to an increase in VA . During pregnancy (PERNOLL et al., 1975) and administration of progesterone (CULLEN et al., 1959; TYLER, 1960; SKATRUD et al., 1978 SKATRUD et al., , 1980 , the increase in VA has been attributed to a greater increase in VE relative to the concomitant increase in physiological dead space ventilation (VD). To our knowledge, however, little has been reported on VE during the menstrual cycle, although the PACO2 has been much studied. HEERHABER (1948) observed in one normal woman that PACO2 continuously decreased during the luteal phase while VE did not increase steadily. Very recently, SCHOENE et al. (1981) reported that twelve menstruating women showed a 24% increase in VE and a 2.3 mmHg decrease in PACO2 during the luteal phase, compared with those occurring during the follicular phase. In our previous study CULLEN et al., 1959; TYLER, 1960; SKATRUD et al., 1978 SKATRUD et al., , 1980 or with no change in Pb (KRYGER et al., 1978) . As a result of this, the VD/VT either decreased by 3-15% (CULLEN et al., 1959; TYLER, 1960; KRYGER et al., 1978) or remained unchanged (SKATRUD et al., 1978 (SKATRUD et al., , 1980 crease. Thus, in the cases of pregnancy and administration of progesterone, the relatively large increases in VA (+10-20%) seem to be due to sufficiently large increases in VE in spite of concomitantly increasing VD. On the other hand, in the case of the luteal phase in our subjects, the relatively small increase in VA (+9.4%) appears to be attributable mostly to the decrease in VD with little change of VE, resulting in a significant decrease in VD/ VT. A significant change in respiratory frequency was not seen after the ovulation in our subjects (Table 1) , this result being in agreement with those obtained after the administration of progesterone (KRYGER et al., 1978; SKATRUD et al., 1978 SKATRUD et al., , 1980 . We cannot yet explain the discrepancies between our findings and those of others. Possible reasons are as follows. (1) The higher the level of blood progesterone, the greater the increase in VE and VT. The levels of blood progesterone during progesterone administration were double during the luteal phase (SKATRUD et al., 1978 (SKATRUD et al., , 1980 and those during pregnancy quadrupled during the luteal phase (GOLDMAN and ZARROW, 1973; TAGATZ and GURPIDE, 1973) . However, SCHOENE et al. (1981) have cast doubts on this possibility. (2) A greater increase in VT tends to be accompanied by a greater increase in VD (BOUHUYS, 1964) . (3) Progesterone possibly decreases the lung compliance (ITO and AVIADO, 1968; FARIDY, 1981) . This effect might result in decreases in FRC (FARIDY, 1981) and the VA/Q ratio, the former leading to a decrease in anatomical dead space and the latter, to a decrease in alveolar dead space (BOUHUYS, 1964) . However, there has been no study made as to whether FRC and/or the VA/Q ratio decrease during the luteal phase. (4) The above two opposing effects of (2) and (3) on VD may offset each other. That is, when the magnitude of increase in VT in response to increased progesterone is smaller, the net increase in VD will be smaller, and in some cases, it will become negative. In the case of our subjects with no significant increases in VT during the luteal phase, their VD values are likely to decrease due to this sequence. In our recent study on a further five menstruating subjects (TAKANO, 1981) , we again observed that there was no significant increase in VE (+0.4%) but a significant decrease in PACO2 (-3.2 mmHg) during the luteal phase. We cannot explain the disagreement between Schoene's subjects (SCHOENE et al., 1981) and ours in regard to the VE response during the luteal phase. Data on the VD of Schoene's subjects have not yet become available. It is not known whether racial differences play a role in the sensitivity and availability of progesterone receptor sites.
